We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Two New Kits Designed to Promote the Study of RNA-Protein Interactions

By LabMedica International staff writers
Posted on 28 Jun 2010
Two related self-contained kits allow molecular biologists to probe RNA-protein complexes using a modernized version the RNA electrophoretic mobility shift assay (EMSA) technique that replaces radioactive labeling with chemiluminescent detection.

The kits are manufactured by two subdivisions of Thermo Fisher Scientific Inc. More...
(Milford, MA, USA). The first is the LightShift RNA EMSA Kit, which the manufacturer says is the first commercially available EMSA kit. The protocol is based on a biotinylated RNA fragment used to probe protein samples. RNA-protein complexes are then monitored by changes in electrophoretic migration patterns. To detect these changes, a chemiluminescent detection method is used that provides sensitivity comparable to detection of a radioactive label.

Preparing the biotinylated probe in-house is made easy with the second kit, the Thermo Scientific Pierce RNA 3' End Biotinylation Kit. This kit provides the reagents required to produce biotinylated RNA probes for use in chemiluminescent or other detection methods. An enzymatic procedure is used to attach a single biotinylated nucleotide to the 3′ end of an RNA strand that is 22 to 450 nucleotides in length. The reaction can be completed in 30 minutes to two hours.

The biotinylated RNA probes produced in-house cost much less than commercial biotinylated RNA probes. The complete kit contains an unlabeled RNA strand to use as a positive control, a biotinylated-RNA probe standard, RNase inhibitor, glycogen, and ligation-enhancing reagents.

Related Links:
Thermo Fisher Scientific Inc.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automatic CLIA Analyzer
Shine i6000
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.